prostate-specific membrane antigen

You have access
¹⁸F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
Matthias Eiber, Markus Kroenke, Alexander Wurzer, Lena Ulbrich, Lena Jooß, Tobias Maurer, Thomas Horn, Kilian Schiller, Thomas Langbein, Gabriel Buschner, Hans-Jürgen Wester and Wolfgang Weber

Journal of Nuclear Medicine May 1, 2020, 61 (5) 696-701; DOI: https://doi.org/10.2967/jnumed.119.234914
You have access
Prospective Evaluation of ¹⁸F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
Hong Song, Caitlyn Harrison, Heying Duan, Kip Guja, Negin Hatami, Benjamin L. Franc, Farshad Moradi, Carina Mari Aparici, Guido A. Davidzon and Andrei Iagaru

Journal of Nuclear Medicine April 1, 2020, 61 (4) 546-551; DOI: https://doi.org/10.2967/jnumed.119.231654
You have access
Prospective Comparison of PET Imaging with PSMA-Targeted ¹⁸F-DCFPyL Versus Na¹⁸F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer
Steven P. Rowe, Xin Li, Bruce J. Trock, Rudolf A. Werner, Sarah Frey, Michael DiGianvittorio, J. Keith Bleiler, Diane K. Reyes, Rehab Abdallah, Kenneth J. Pienta, Michael A. Gorin and Martin G. Pomper

Journal of Nuclear Medicine February 1, 2020, 61 (2) 183-188; DOI: https://doi.org/10.2967/jnumed.119.227793
You have access
Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye–Protein Interaction
Albertus W. Hensbergen, Tessa Buckle, Danny M. van Willigen, Margret Schottelius, Mick M. Welling, Felicia A. van der Wijk, Tobias Maurer, Henk G. van der Poel, Gabri van der Pluijm, Wytske M. van Weerden, Hans-Jürgen Wester and Fijs W.B. van Leeuwen

Journal of Nuclear Medicine February 1, 2020, 61 (2) 234-241; DOI: https://doi.org/10.2967/jnumed.119.233064
You have access
Prospective Evaluation of PSMA-Targeted ¹⁸F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer
Steven P. Rowe, Scott P. Campbell, Margarita Mana-Ay, Zsolt Szabo, Mohamad E. Allaf, Kenneth J. Pienta, Martin G. Pomper, Ashley E. Ross and Michael A. Gorin

Journal of Nuclear Medicine January 1, 2020, 61 (1) 58-61; DOI: https://doi.org/10.2967/jnumed.119.226514
You have access
Preclinical Evaluation of ^203/212Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer
Sangeeta Ray Banerjee, Il Minn, Vivek Kumar, Anders Josefsson, Ala Lisok, Mary Brummet, Jian Chen, Ana P. Kiess, Kwamena Baidoo, Cory Brayton, Ronnie C. Mease, Martin Brechbiel, George Sgouros, Robert F. Hobbs and Martin G. Pomper

Journal of Nuclear Medicine January 1, 2020, 61 (1) 80-88; DOI: https://doi.org/10.2967/jnumed.119.229393
You have access
¹⁷⁷Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney
Jingjing Zhang, Harshad R. Kulkarni, Aviral Singh, Christiane Schuchardt, Karin Niepsch, Thomas Langbein and Richard P. Baum

Journal of Nuclear Medicine November 1, 2019, 60 (11) 1579-1586; DOI: https://doi.org/10.2967/jnumed.118.223149
You have access
First Clinicopathologic Evidence of a Non–PSMA-Related Uptake Mechanism for ⁶⁸Ga-PSMA-11 in Salivary Glands
Niels J. Rupp, Christoph A. Umbricht, Daniele A. Pizzuto, Daniela Lenggenhager, Antonia Töpfer, Julian Müller, Urs J. Muehlematter, Daniela A. Ferraro, Michael Messerli, Grégoire B. Morand, Gerhard F. Huber, Daniel Eberli, Roger Schibli, Cristina Müller and Irene A. Burger

Journal of Nuclear Medicine September 1, 2019, 60 (9) 1270-1276; DOI: https://doi.org/10.2967/jnumed.118.222307
You have access
⁶⁸Ga-PSMA-11 PET/MR Detects Local Recurrence Occult on mpMRI in Prostate Cancer Patients After HIFU
Irene A. Burger, Julian Müller, Olivio F. Donati, Daniela A. Ferraro, Michael Messerli, Benedikt Kranzbühler, Edwin E.G.W. ter Voert, Urs J. Muehlematter, Niels J. Rupp, Ashkan Mortezavi and Daniel Eberli

Journal of Nuclear Medicine August 1, 2019, 60 (8) 1118-1123; DOI: https://doi.org/10.2967/jnumed.118.221564
You have access
Clinical Outcomes of ¹⁷⁷Lu-PSMA Radioligand Therapy in Earlier and Later Phases of Metastatic Castration-Resistant Prostate Cancer Grouped by Previous Taxane Chemotherapy
Thomas W. Barber, Aviral Singh, Harshad R. Kulkarni, Karin Niepsch, Baki Billah and Richard P. Baum

Journal of Nuclear Medicine July 1, 2019, 60 (7) 955-962; DOI: https://doi.org/10.2967/jnumed.118.216820

Main menu

User menu

Search

prostate-specific membrane antigen

Pages